Absorbable medical hemostatic material and preparation process thereof
A hemostatic material and preparation process technology, applied in the field of medical materials, can solve the problems to be further improved, and achieve the effects of good market application prospects, safe and reliable use, and strong anti-infection ability.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0024] An absorbable medical hemostatic material, prepared from the following components in parts by weight: 18 parts of fish scale collagen, 10 parts of maltodextrin, 5 parts of mannuronic acid oligosaccharides, 3 parts of potassium alginate, D- 2 parts of threitol, 4 parts of polycaprolactone, 1 part of 0.7mol / L alcoholic extract of Angelica dahurica, 1.5 parts of oxaloacetic acid, 2 parts of carboxylated dextran, 1.8 parts of γ-polyglutamic acid, ethyl glycinate 0.5 parts, 1.2 parts of sodium D-glucuronate, 0.3 parts of microcrystalline cellulose 101, 1.8 parts of L-guluronic acid pentasaccharide, 0.4 parts of citric acid, and 55 parts of distilled water.
[0025] The preparation process of the absorbable medical hemostatic material comprises the following preparation steps:
[0026] Step 1) weighing according to the above weight ratio;
[0027] Step 2) Dissolve citric acid and γ-polyglutamic acid in 1 / 2 distilled water, then add fish scale collagen and maltodextrin, heat ...
Embodiment 2
[0032] An absorbable medical hemostatic material, prepared by the following components in parts by weight: 26 parts of fish scale collagen, 19 parts of maltodextrin, 11 parts of mannuronic acid oligosaccharides, 7 parts of potassium alginate, D- 5 parts of threitol, 9 parts of polycaprolactone, 4 parts of 0.7mol / L alcoholic extract of Angelica dahurica, 3.8 parts of oxaloacetic acid, 6 parts of carboxylated dextran, 4 parts of γ-polyglutamic acid, ethyl glycinate 2.3 parts, 3.5 parts of sodium D-glucuronate, 2 parts of microcrystalline cellulose, 3 parts of L-guluronic acid pentasaccharide, 1.6 parts of citric acid, and 85 parts of distilled water.
[0033] The preparation process of the absorbable medical hemostatic material comprises the following preparation steps:
[0034] Step 1) weighing according to the above weight ratio;
[0035] Step 2) Dissolve citric acid and γ-polyglutamic acid in 1 / 2 distilled water, then add fish scale collagen and maltodextrin, heat and stir t...
Embodiment 3
[0040] An absorbable medical hemostatic material, prepared from the following components in parts by weight: 19 parts of fish scale collagen, 12 parts of maltodextrin, 7 parts of mannuronic acid oligosaccharides, 3.5 parts of potassium alginate, D- 2.6 parts of threitol, 4.5 parts of polycaprolactone, 1.5 parts of 0.7mol / L alcoholic extract of Angelica dahurica, 1.9 parts of oxaloacetic acid, 2.4 parts of carboxylated dextran, 2.1 parts of γ-polyglutamic acid, ethyl glycinate 0.8 parts, 1.4 parts of sodium D-glucuronate, 0.4 parts of microcrystalline cellulose 101, 2 parts of L-guluronic acid pentasaccharide, 0.5 parts of citric acid, and 62 parts of distilled water.
[0041] The preparation process of the absorbable medical hemostatic material comprises the following preparation steps:
[0042] Step 1) weighing according to the above weight ratio;
[0043] Step 2) Dissolve citric acid and γ-polyglutamic acid in 1 / 2 distilled water, then add fish scale collagen and maltodextr...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com